1. There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: a review of current practice and recommendations for improved effectiveness;Makover;Am. J. Prev. Cardiol.,2022
2. The evolving understanding and approach to residual cardiovascular risk management;Dhindsa;Front. Cardiovasc. Med.,2020
3. Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia;Ferrari;Eur. Heart J. Suppl.,2016
4. Targeting residual inflammatory risk: a shifting paradigm for atherosclerotic disease;Aday;Front. Cardiovasc. Med.,2019
5. Inflammation in plaque erosion and rupture;Huynh;Nat. Rev. Cardiol.,2022